Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues
Expenses:        
Research and development 7,434,000 6,109,000 14,646,000 12,927,000
General and administrative 5,457,000 5,538,000 12,025,000 11,950,000
Depreciation and amortization 824,000 834,000 1,641,000 2,899,000
Licensed technology impairment charge 32,916,000
Total expenses 13,715,000 12,481,000 28,312,000 60,692,000
Loss from operations (13,715,000) (12,481,000) (28,312,000) (60,692,000)
Interest and miscellaneous income 8,000 271,000 23,000 923,000
Interest expense (1,500,000) (800,000) (2,920,000) (1,400,000)
Net loss $ (15,207,000) $ (13,010,000) $ (31,209,000) $ (61,169,000)
Basic and diluted loss per common share $ (0.16) $ (0.14) $ (0.33) $ (0.66)
Weighted average number of common shares outstanding – basic and diluted 96,509,783 92,704,203 95,378,503 92,533,354
Other comprehensive (loss)/income:        
Change in unrealized (losses)/gains related to available-for-sale debt securities $ (4,000) $ (253,000) $ 9,000 $ 133,000
Comprehensive loss $ (15,211,000) $ (13,263,000) $ (31,200,000) $ (61,036,000)